Palisade Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Palisade Bio
PALI Stock  USD 1.90  0.12  5.94%   
Palisade Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Palisade Bio's valuation are provided below:
Market Capitalization
283.5 M
Enterprise Value Revenue
234.8894
Earnings Share
(2.07)
We have found one hundred twenty available trending fundamental ratios for Palisade Bio, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Palisade Bio recent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 4.4 M. The Palisade Bio's current Enterprise Value is estimated to increase to about (8.8 M)

Palisade Bio Total Revenue

250,000

Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 K, Interest Expense of 13.1 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 17.64, Dividend Yield of 0.0 or PTB Ratio of 0.29. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
  
Build AI portfolio with Palisade Stock
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Palisade Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.7 M12.5 M12.3 M
Very volatile
Short and Long Term Debt Total144.5 K152.1 K3.3 M
Slightly volatile
Other Current Liabilities1.6 M2.3 M1.5 M
Pretty Stable
Total Current Liabilities3.2 M3.7 M3.5 M
Very volatile
Property Plant And Equipment Net95 K100 K199.7 K
Slightly volatile
Accounts Payable1.5 M1.3 M1.4 M
Very volatile
Cash8.2 M11.3 M8.4 M
Pretty Stable
Non Current Assets Total421.7 K443.9 K1.1 M
Slightly volatile
Cash And Short Term Investments10 M11.3 M10.4 M
Very volatile
Common Stock Shares Outstanding1.7 M1.6 M519.3 K
Slightly volatile
Liabilities And Stockholders Equity11.7 M12.5 M12.3 M
Very volatile
Non Current Liabilities Total130 K136.8 K1.8 M
Slightly volatile
Other Stockholder Equity135.2 M164.9 M144.1 M
Pretty Stable
Total Liabilities5.3 M3.9 M5.4 M
Pretty Stable
Total Current Assets10.6 M12.1 M11.2 M
Very volatile
Short Term Debt144.5 K152.1 K1.2 M
Slightly volatile
Common Stock23.1 K24.3 K224.3 K
Slightly volatile
Common Stock Total Equity147.9 K155.7 K332.7 K
Slightly volatile
Other Current Assets555.9 K746.4 K583.8 K
Slightly volatile
Property Plant And Equipment Gross154 K78.3 K187.7 K
Slightly volatile
Intangible Assets160.7 K169.2 K551.4 K
Slightly volatile
Net Receivables26.2 K27.6 K201.9 K
Very volatile
Short Term Investments13.7 K14.4 K5.5 M
Slightly volatile
Capital Surpluse245.4 M285 M227.2 M
Slightly volatile
Property Plant Equipment167.9 K100.8 K204.8 K
Slightly volatile
Other Liabilities1.7 M3 M1.2 M
Slightly volatile
Long Term Debt75.2 K84.6 K92.3 K
Slightly volatile
Capital Lease Obligations161.4 K81 K238.3 K
Slightly volatile
Deferred Long Term Liabilities1.5 M1.6 M1.8 M
Slightly volatile
Short and Long Term Debt67.5 K71.1 K709.9 K
Slightly volatile
Capital Stock24.8 K26.1 K38.8 K
Pretty Stable
Non Current Liabilities Other128.2 K135 K1.4 M
Slightly volatile

Palisade Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.6 K2.7 K147.7 K
Slightly volatile
Interest Expense13.1 K13.8 K526.7 K
Pretty Stable
Other Operating Expenses14.8 M17.1 M14.9 M
Slightly volatile
Research Development6.9 M10.4 M6.8 M
Pretty Stable
Total Operating Expenses14.5 M17.1 M14.9 M
Slightly volatile
Selling General Administrative6.5 M6.7 M6.2 M
Slightly volatile
Selling And Marketing Expenses4.4 K4.6 K383.6 K
Pretty Stable
Interest Income24.6 K25.9 K506.3 K
Pretty Stable
Reconciled Depreciation3.3 K3.5 K3 K
Pretty Stable

Palisade Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation2.6 K2.7 K139.2 K
Slightly volatile
Total Cash From Financing Activities11.2 M11 M10.9 M
Very volatile
End Period Cash Flow8.2 M11.3 M8.4 M
Pretty Stable
Stock Based Compensation557.5 K586.8 K1.9 M
Slightly volatile
Begin Period Cash Flow8 M14.3 M8.4 M
Pretty Stable
Change To Netincome17.2 M16.4 M6.4 M
Slightly volatile
Issuance Of Capital Stock9.4 M7.6 M5.1 M
Slightly volatile
Dividends Paid79.2 K89.1 K97.3 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.6418.562.5 M
Slightly volatile
Days Sales Outstanding236248602
Pretty Stable
Average Payables667.8 K768.4 K1.1 M
Slightly volatile
Stock Based Compensation To Revenue2.132.2546.2119
Slightly volatile
Capex To Depreciation2.123.832.081
Slightly volatile
Sales General And Administrative To Revenue21.2122.33136
Pretty Stable
Research And Ddevelopement To Revenue23.5724.81178
Pretty Stable
Capex To Revenue0.01370.01444.1254
Slightly volatile
Cash Per Share7.587.98247
Pretty Stable
Income Quality0.60.760.7632
Pretty Stable
Intangibles To Total Assets0.05230.09140.0837
Pretty Stable
Current Ratio3.192.923.7765
Pretty Stable
Receivables Turnover1.851.9422.4746
Slightly volatile
Capex Per Share0.00960.01012.7368
Slightly volatile
Average Receivables112.5 K170.6 K191.5 K
Pretty Stable
Revenue Per Share0.60.631.3587
Slightly volatile
Interest Debt Per Share0.140.1565.8935
Pretty Stable
Debt To Assets0.0170.01790.2583
Slightly volatile
Operating Cycle236248602
Pretty Stable
Ebt Per Ebit1.131.121.0354
Pretty Stable
Quick Ratio3.192.923.7765
Pretty Stable
Net Income Per E B T1.11.141.0101
Slightly volatile
Cash Ratio2.632.732.9527
Slightly volatile
Days Of Sales Outstanding236248602
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.121.151.0305
Pretty Stable
Fixed Asset Turnover2.671.381.6971
Slightly volatile
Debt Ratio0.0170.01790.2583
Slightly volatile
Price Sales Ratio17.6418.562.5 M
Slightly volatile
Asset Turnover0.01940.02050.0515
Slightly volatile
Gross Profit Margin2.264.334.3956
Very volatile

Palisade Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.4 M4.6 M56.7 B
Slightly volatile

Palisade Fundamental Market Drivers

Palisade Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Palisade Bio Financial Statements

Investors use fundamental indicators, such as Palisade Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Palisade Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-4.1 M-3.9 M
Cost Of Revenue3.5 K3.6 K
Stock Based Compensation To Revenue 2.25  2.13 
Sales General And Administrative To Revenue 22.33  21.21 
Research And Ddevelopement To Revenue 24.81  23.57 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.63  0.60 
Ebit Per Revenue(60.12)(63.13)

Currently Active Assets on Macroaxis

GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
GOOGAlphabet Inc Class C
GMGeneral Motors
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
How To Invest In Palisade
Details
Is Palisade Stock a good investment?
Details
What is Palisade Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.88)
Return On Equity
(2.29)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY